트렘피어(Tremfya) 시장 규모, 점유율, 동향, 산업 분석 리포트 : 용도별(플라크 건선, 건선성 관절염, 기타), 유통 채널별, 지역별 - 시장 예측(2025-2034년)

The global tremfya market size is expected to reach USD 7.99 billion by 2034, according to a new study by Polaris Market Research. The report "Tremfya Market Size, Share, Trends, Industry Analysis Report By Application [Plaque Psoriasis, Psoriatic Arthritis (PsA), Others], By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Tremfya market is centered around the global sales and distribution of guselkumab, a biologic medication. This advanced treatment specifically targets interleukin-23 (IL-23), a protein in the immune system that plays a key role in inflammatory responses. Tremfya is primarily used to manage chronic conditions such as moderate-to-severe plaque psoriasis and active psoriatic arthritis, aiming to reduce inflammation and improve patient symptoms. Recently, its use has expanded to include moderately to severely active ulcerative colitis and Crohn's disease, broadening its application and patient reach.

The Tremfya market growth is largely driven by the increasing global prevalence of these chronic inflammatory diseases. As more people are diagnosed with conditions such as plaque psoriasis and psoriatic arthritis, the demand for effective and long-term treatments continues to rise. Additionally, Tremfya's strong clinical profile, demonstrating significant efficacy in improving symptoms and quality of life for patients, is a major growth factor. Its ability to offer durable outcomes and, in some cases, inhibit disease progression, makes it a preferred option for healthcare providers and patients seeking advanced therapeutic solutions.

Tremfya Market Report Highlights:

By application, the plaque psoriasis segment held the largest share of the Tremfya market in 2024. This is mainly because plaque psoriasis affects a large number of people worldwide, and Tremfya has shown strong results in helping patients achieve clear or almost clear skin.

By distribution channel, the hospital pharmacies segment held the largest share in 2024. This is due to the rising need for specialized handling and administration of biologic drugs, often performed in hospital settings, and the fact that specialists who prescribe these complex treatments are frequently based in hospitals.

By region, North America held the largest share in 2024. This dominance is driven by the high prevalence of target diseases in the region, a well-developed healthcare infrastructure that supports advanced biologic therapies, and a generally higher willingness to adopt innovative and often high-cost treatments. Asia Pacific is an emerging and rapidly expanding market for Tremfya. While the prevalence of chronic inflammatory diseases may historically have been perceived as lower in some parts of this region, increasing urbanization, lifestyle changes, and improved diagnostic capabilities are contributing to a rise in reported cases.

Johnson & Johnson is the current manufacturer of Tremfya.

Polaris Market Research has segmented the Tremfya market report based on application, distribution channel, and region:

By Application Outlook (Revenue - USD Billion, 2020-2034)

Plaque Psoriasis

Psoriatic Arthritis (PsA)

Others

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Tremfya Market Insights

• 4.1. Tremfya Market - Market Snapshot
• 4.2. Pipeline Analysis
  • 4.2.1. Impact of Tremfya Access Programs on Uninsured and Underinsured Patients
• 4.3. Market Concentration & Characteristics
• 4.4. Tremfya Market Dynamics
  • 4.4.1. Drivers and Opportunities
    • 4.4.1.1. Rising Prevalence of Target Diseases
    • 4.4.1.2. Demonstrated Clinical Efficacy and Expanding Indications
  • 4.4.2. Restraints and Challenges
    • 4.4.2.1. High treatment cost and reimbursement limitations
• 4.5. Porter's Five Forces Analysis
  • 4.5.1. Bargaining Power of Suppliers (Moderate)
  • 4.5.2. Threats of New Entrants: (Low)
  • 4.5.3. Bargaining Power of Buyers (Moderate)
  • 4.5.4. Threat of Substitute (Moderate)
  • 4.5.5. Rivalry among existing firms (High)
• 4.6. PESTEL Analysis
• 4.7. Tremfya Market Trends
• 4.8. Value Chain Analysis
• 4.9. COVID-19 Impact Analysis

5. Global Tremfya Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Tremfya Market, by Application, 2020-2034 (USD Billion)
• 5.3. Plaque Psoriasis
  • 5.3.1. Global Tremfya Market, by Plaque Psoriasis, by Region, 2020-2034 (USD Billion)
• 5.4. Psoriatic Arthritis (PsA)
  • 5.4.1. Global Tremfya Market, by Psoriatic Arthritis (PsA), by Region, 2020-2034 (USD Billion)
• 5.5. Others
  • 5.5.1. Global Tremfya Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Tremfya Market, by Distribution Channel

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
• 6.3. Hospital Pharmacies
  • 6.3.1. Global Tremfya Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
• 6.4. Retail Pharmacies
  • 6.4.1. Global Tremfya Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
• 6.5. Online Pharmacies
  • 6.5.1. Global Tremfya Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)

7. Global Tremfya Market, by Geography

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Tremfya Market Assessment, By Geography, 2020-2034 (USD Billion)
• 7.3. Tremfya Market - North America
  • 7.3.1. North America: Tremfya Market, by Application, 2020-2034 (USD Billion)
  • 7.3.2. North America: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3.3. Tremfya Market - U.S.
    • 7.3.3.1. U.S.: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3.2. U.S.: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3.4. Tremfya Market - Canada
    • 7.3.4.1. Canada: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4.2. Canada: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
• 7.4. Tremfya Market - Europe
  • 7.4.1. Europe: Tremfya Market, by Application, 2020-2034 (USD Billion)
  • 7.4.2. Europe: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.3. Tremfya Market - UK
    • 7.4.3.1. UK: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3.2. UK: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.4. Tremfya Market - France
    • 7.4.4.1. France: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4.2. France: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.5. Tremfya Market - Germany
    • 7.4.5.1. Germany: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5.2. Germany: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.6. Tremfya Market - Italy
    • 7.4.6.1. Italy: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6.2. Italy: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.7. Tremfya Market - Spain
    • 7.4.7.1. Spain: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7.2. Spain: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.8. Tremfya Market - Netherlands
    • 7.4.8.1. Netherlands: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8.2. Netherlands: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.9. Tremfya Market - Russia
    • 7.4.9.1. Russia: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9.2. Russia: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4.10. Tremfya Market - Rest of Europe
    • 7.4.10.1. Rest of Europe: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10.2. Rest of Europe: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
• 7.5. Tremfya Market - Asia Pacific
  • 7.5.1. Asia Pacific: Tremfya Market, by Application, 2020-2034 (USD Billion)
  • 7.5.2. Asia Pacific: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.3. Tremfya Market - China
    • 7.5.3.1. China: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3.2. China: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.4. Tremfya Market - India
    • 7.5.4.1. India: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4.2. India: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.5. Tremfya Market - Malaysia
    • 7.5.5.1. Malaysia: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5.2. Malaysia: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.6. Tremfya Market - Japan
    • 7.5.6.1. Japan: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6.2. Japan: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.7. Tremfya Market - Indonesia
    • 7.5.7.1. Indonesia: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7.2. Indonesia: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.8. Tremfya Market - South Korea
    • 7.5.8.1. South Korea: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8.2. South Korea: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.9. Tremfya Market - Australia
    • 7.5.9.1. Australia: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9.2. Australia: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5.10. Tremfya Market - Rest of Asia Pacific
    • 7.5.10.1. Rest of Asia Pacific: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10.2. Rest of Asia Pacific: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
• 7.6. Tremfya Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Tremfya Market, by Application, 2020-2034 (USD Billion)
  • 7.6.2. Middle East & Africa: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.6.3. Tremfya Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3.2. Saudi Arabia: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.6.4. Tremfya Market - UAE
    • 7.6.4.1. UAE: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4.2. UAE: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.6.5. Tremfya Market - Israel
    • 7.6.5.1. Israel: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5.2. Israel: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.6.6. Tremfya Market - South Africa
    • 7.6.6.1. South Africa: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6.2. South Africa: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.6.7. Tremfya Market - Rest of Middle East & Africa
    • 7.6.7.1. Rest of Middle East & Africa: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7.2. Rest of Middle East & Africa: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
• 7.7. Tremfya Market - Latin America
  • 7.7.1. Latin America: Tremfya Market, by Application, 2020-2034 (USD Billion)
  • 7.7.2. Latin America: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.7.3. Tremfya Market - Mexico
    • 7.7.3.1. Mexico: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3.2. Mexico: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.7.4. Tremfya Market - Brazil
    • 7.7.4.1. Brazil: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4.2. Brazil: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.7.5. Tremfya Market - Argentina
    • 7.7.5.1. Argentina: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5.2. Argentina: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.7.6. Tremfya Market - Rest of Latin America
    • 7.7.6.1. Rest of Latin America: Tremfya Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6.2. Rest of Latin America: Tremfya Market, by Distribution Channel, 2020-2034 (USD Billion)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Johnson & Johnson
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development